Moberg Research, Inc. recalls Moberg Component Neuromonitoring System (CNS Monitor)-Intended as a short-term neurological monitoring system that coll…

Recall date

February 20, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

Z-1338-2023

FDA classification

Class II

Brand / firm

Moberg Research, Inc.

Sold / distributed

Worldwide distribution - US Nationwide and the countries of France, Germany, Italy, Sweden.

Why it was recalled

Battery leakage can cause corrosion to the metal enclosure near the electrical interface. Prolonged contact to corrosive materials could cause injury to skin. DOC

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Moberg Component Neuromonitoring System (CNS Monitor)-Intended as a short-term neurological monitoring system that collects, displays, and stores multiple physiological measurements Model: CNS-350